Forge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 200,000 square foot facility in Columbus, Ohio, the Hearth, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more, visit www.forgebiologics.com
Newcells Biotech are a fast-growing team of global scientific and industry experts based in the Helix Science Campus of Newcastle-upon-Tyne in the UK. We provide in vitro models to most accurately predict in vivo outcomes, building confidence in the decision making process. Using our expertise in iPSCs, cellular physiology and organoid technology, we have built functional pre-clinical in vitro models of the retina in the form of fully developed retinal organoids and RPE cells.
Translational Imaging Innovations
Translational Imaging Innovations, Inc. (TII) was formed in 2019 as a spin-out of the Advanced Ocular Imaging Program of the Medical College of Wisconsin to accelerate image-driven innovations in ophthalmology. The TII Integrated Translational Imaging™ platform combines a scalable and extensible database with data automation workflows for biomarker discovery and clinical endpoint validation. Our objective is to dramatically increase access to ophthalmic images and data for empowering breakthroughs in next-generation ocular therapies.